No time to wait
Ray, K.N. Chari, A.V. Engberg, J. Bertolet, M. Mehrotra, A.
Marnie Bertolet
Bertolet Marnie / Marianne Bertolet
ORCID: 0000-0002-5799-9033
A cross-sectional association of obesity with coronary calcium among Japanese, Koreans, Japanese Americans, and US Whites 10.1093/ehjci/jet080
Do differences in risk factors explain the lower rates of coronary heart disease in japanese versus U.S. women 10.1089/jwh.2012.4087
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 10.1161/CIR.0b013e31827e8e5f
ACCF/AHA clinical practice guideline methodology summit report: A report of the American college of cardiology foundation/American heart association task force on practice guidelines 10.1016/j.jacc.2012.09.025
Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort 10.1097/QAD.0000000000000471
Risk factor control for coronary artery disease secondary prevention in large randomized trials 10.1016/j.jacc.2013.01.044
Validity of birth certificate-derived maternal weight data 10.1111/ppe.12120
Supply and utilization of pediatric subspecialists in the United States 10.1542/peds.2013-3466
Epidural steroid injections in the treatment of lumbar spinal stenosis efficacy and predictability of successful response 10.1097/PHM.0b013e31822dea76
Measuring β-cell function relative to insulin sensitivity in youth: Does the hyperglycemic clamp suffice? 10.2337/dc12-1508
Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial 10.1177/2047487314544046
Tree-based identification of subgroups for time-varying covariate survival data 10.1177/0962280212460442
Risk factors for incident peripheral arterial disease in type 2 diabetes: Results from the bypass angioplasty revascularization investigation in type 2 diabetes (BARI 2D) trial 10.2337/dc13-2303
Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: Population based prospective cohort study 10.1136/heartjnl-2013-304421
Disparities in time spent seeking medical care in the United States 10.1001/jamainternmed.2015.4468
Comprehensive cardiovascular risk factor control improves survival: The BARI 2D trial 10.1016/j.jacc.2015.06.019
Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy 10.1016/j.urology.2012.10.080
Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) 10.1161/CIRCINTERVENTIONS.111.963512
Prognosis and conditional disease-free survival among patients with ovarian cancer 10.1200/JCO.2014.55.1713
Nonesterified fatty acids and spontaneous preterm birth: A factor analysis for identification of risk patterns 10.1093/aje/kwu037
Risk factors for cranial nerve deficits during carotid endarterectomy: A retrospective study 10.1016/j.clineuro.2014.12.017
Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy 10.1007/s00345-014-1430-2
Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts 10.1186/1471-2466-14-75
Development of the Telehealth Usability Questionnaire (TUQ) 10.5195/ijt.2016.6196
Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease 10.1097/QAD.0000000000001365
Prognostic Value of Adipokines in Predicting Cardiovascular Outcome: Explaining the Obesity Paradox 10.1016/j.mayocp.2016.03.020
Neonatal outcomes following preterm birth classified according to placental features 10.1016/j.ajog.2016.12.022
Value of anterosuperior rotator cuff and labral tears at MRI for predicting long head of biceps tearing at arthroscopy 10.1016/j.crad.2018.08.007
Radiographic emphysema, circulating bone biomarkers, and progressive bone mineral density loss in smokers 10.1513/AnnalsATS.201709-743OC
Lipoprotein Heterogeneity Early in Pregnancy and Preterm Birth 10.1055/s-0037-1603471
Utility and safety of adenosine challenge for subtle ventricular pre-excitation in the pediatric population 10.1111/jce.13935
Breastfeeding greater than 6 months is associated with smaller maternal waist circumference up to one decade after delivery 10.1089/jwh.2018.7393
A Randomized Clinical Trial of Wheeled Mobility for Pressure Injury Prevention and Better Function 10.1111/jgs.15495
Common carotid artery intima-media thickness increases throughout the pregnancy cycle: A prospective cohort study 10.1186/s12884-018-1841-y
Blood pressure patterns and subsequent coronary artery calcification in women who delivered preterm births 10.1161/HYPERTENSIONAHA.117.10693
Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort 10.1016/j.oraloncology.2018.07.013
The effect of frailty on HAI response to influenza vaccine among community-dwelling adults ≥ 50 years of age 10.1080/21645515.2017.1405883
Effect of patient age on accuracy of primary MRI signs of long head of biceps tearing and instability in the shoulder: an MRI-arthroscopy correlation study 10.1007/s00256-017-2783-6
Commentary on Engen et al: Risk-based, dynamic, process-oriented monitoring strategies and their burden 10.1177/1740774519881617
Early pregnancy immune profile and preterm birth classified according to uteroplacental lesions. 10.1016/j.placenta.2019.12.007
D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. 10.1016/j.ajog.2020.05.048
Changes in Cardiometabolic Risk Factors Before and After Gestational Diabetes: A Prospective Life-Course Analysis in CARDIA Women. 10.1002/oby.22848
Life Course Changes in Cardiometabolic Risk Factors Associated With Preterm Delivery: The 30-Year CARDIA Study. 10.1161/jaha.119.015900
The effectiveness of an operating room etiquette video on medical student comfort in the gynecologic operating room 10.4103/ehp.ehp_27_20
The design of a Bayesian platform trial to prevent and eradicate inhibitors in patients with hemophilia. 10.1182/bloodadvances.2020002789
Spirituality, quality of life and frailty in community-dwelling adults ≥ 50 years. 10.1037/rel0000387
Grey Literature Searching for Health Sciences Systematic Reviews: A Prospective Study of Time Spent and Resources Utilized 10.18438/B8DW3K
Prognosis and conditional disease-free survival among ovarian cancer patients 10.1158/1538-7445.AM2014-LB-273
Associations between Inflammatory Markers and Subclinical Atherosclerosis in Middle-aged White, Japanese-American and Japanese Men: The ERA-JUMP Study 10.5551/JAT.23580
Preinfertility Referral Patterns Patient Characteristics That Influence Evaluation and Treatment 10.1097/01.AOG.0000463696.95337.D5
Preterm Delivery and Patterns of Cardiometabolic Risk Factors Pre- and Post-Childbearing: Coronary Artery Risk Development in Young Adults Study 10.1161/CIRC.139.SUPPL_1.MP61
Gestational Diabetes and Patterns of Cardiometabolic Risk Factors Before and After Childbearing: Coronary Artery Risk Development in Young Adults Study 10.1161/CIRC.139.SUPPL_1.P263
Meta-analysis of effect of hormone therapies on lipid levels in breast cancer patients 10.1200/JCO.2019.37.15_SUPPL.E18243
Joseph Ross
Ross Joseph
ORCID: 0000-0002-9218-3320
Physician Network Connections Associated With Faster De-Adoption of Dronedarone for Permanent Atrial Fibrillation 10.1161/CIRCOUTCOMES.121.008040
Guest authorship and ghostwriting in publications related to rofecoxib: A case study of industry documents from rofecoxib litigation 10.1001/jama.299.15.1800
National trends in US hospital admissions for hyperglycemia and hypoglycemia among medicare beneficiaries, 1999 to 2011 10.1001/jamainternmed.2014.1824
Hospital Characteristics Associated with Risk-standardized Readmission Rates 10.1097/MLR.0000000000000713
Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: Retrospective cohort study 10.1136/bmj.h411
Laboratory test ordering at physician offices with and without on-site laboratories 10.1007/s11606-010-1409-7
Certificate of need regulation and cardiac catheterization appropriateness after acute myocardial infarction 10.1161/CIRCULATIONAHA.106.658377
The cost of pharmaceutical innovation to patients 10.1517/17460441.2.11.1431
Association of hospital volume with readmission rates: A Retrospective cross-sectional study 10.1136/BMJ.h447
HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: Observational population based study 10.1136/bmj.h6138
Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients 10.1016/j.ophtha.2016.10.036
Use of stroke secondary prevention services: Are there disparities in care? 10.1161/STROKEAHA.108.539619
Cognitive decline among patients with chronic obstructive pulmonary disease 10.1164/rccm.200902-0276OC
Marketing to physicians in a digital world 10.1056/NEJMp1408974
Direct-to-consumer television advertising: Time to turn off the tube? 10.1007/s11606-013-2424-2
Commentary: Diagnostic devices in clinical trials have high stakes for patient care 10.1136/bmj.i5197
Use of ezetimibe in the United States and Canada 10.1056/NEJMsa0801461
We can see the (Risks of U.V) light 10.1001/jamainternmed.2014.6703
When choosing statin therapy: The case for generics 10.1001/jamainternmed.2013.1529
Publication of pivotal efficacy trials for novel therapeutic agents approved between 2005 and 2011: A cross-sectional study 10.1001/jamainternmed.2014.3438
Use of recommended ambulatory care services: Is the veterans affairs quality gap narrowing? 10.1001/archinte.168.9.950
Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: A population-based analysis 10.1016/j.jacc.2010.05.014
Financial Stress and Outcomes after Acute Myocardial Infarction 10.1371/journal.pone.0047420
US cardiologist workforce from 1995 To 2007: Modest growth, lasting geographic maldistribution especially in rural areas 10.1377/hlthaff.2011.0255
Generic atorvastatin and health care costs 10.1056/NEJMp1113112
Self-reported and actual beta-blocker prescribing for heart failure patients: Physician predictors 10.1371/journal.pone.0008522
Accounting For Patients' Socioeconomic Status Does Not Change Hospital Readmission Rates 10.1377/hlthaff.2015.0394
Guest authorship, mortality reporting, and integrity in rofecoxib studies - Reply 10.1001/jama.300.8.904-c
Assessing the impact of screening colonoscopy on mortality in the medicare population 10.1007/s11606-011-1816-4
Health care choices and decisions in the United States and Canada 10.1001/jama.2009.1566
Trial evidence and approval of therapeutic agents: In reply 10.1001/jama.2014.3420
Regulatory review of new therapeutic agents - FDA versus EMA, 2011-2015 10.1056/NEJMc1700103
Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline 10.1016/j.jacc.2016.10.053
CONSORT Statement for randomized Trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic Trial Abstracts 10.7326/M17-0046
Usual source of care and outcomes following acute myocardial infarction 10.1007/s11606-014-2794-0
Descriptions and interpretations of the ACCORD-lipid trial in the news and biomedical literature: A cross-sectional analysis 10.1001/jamainternmed.2014.1371
Estimating and reporting on the quality of inpatient stroke care by veterans health administration medical centers 10.1161/CIRCOUTCOMES.111.961474
Obstacles to the adoption of biosimilars for chronic diseases 10.1001/jama.2017.5202
Assessing the potential clinical impact of reciprocal drug approval legislation on access to novel therapeutics in the USA: A cohort study 10.1136/bmjopen-2016-014582
Use of administrative claims models to assess 30-day mortality among veterans health administration hospitals 10.1097/MLR.0b013e3181dbe35d
High-deductible health plans and higher-value decisions: A mirageor are we just not there yet? 10.1001/jamainternmed.2015.7559
On chlorofluorocarbon bans and inhaled albuterol prices 10.1001/jamainternmed.2015.1696
Evolution of breast cancer screening in the medicare population: Clinical and economic implications 10.1093/jnci/dju159
Characteristics of novel therapeutics and postmarket safety events - Reply 10.1001/jama.2017.11517
Do imaging studies performed in physician offices increase downstream utilization? An empiric analysis of cardiac stress testing with imaging 10.1016/j.jcmg.2011.04.003
Attitudes of hospital leaders toward publicly reported measures of health care quality 10.1001/jamainternmed.2014.5161
Regional density of cardiologists and rates of mortality for acute myocardial infarction and heart failure 10.1161/CIRCOUTCOMES.113.000214
Quality of care for acute myocardial infarction at urban safety-net hospitals 10.1377/hlthaff.26.1.238
National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study 10.1016/j.ahj.2015.05.012
BRIEF REPORT: Housestaff adherence to cervical cancer screening recommendations 10.1111/j.1525-1497.2005.0279.x
Expanding the frontier of outcomes measurement for reporting public 10.1161/CIRCOUTCOMES.110.959908
Racial and ethnic differences in personal cervical cancer screening amongst post-graduate physicians: Results from a cross-sectional survey 10.1186/1471-2458-8-378
Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer 10.1007/s10549-013-2656-1
Despite federal legislation, shortages of drugs used in acute care settings remain persistent and prolonged 10.1377/hlthaff.2015.1157
Potential overtreatment of diabetes mellitus in older adults with tight glycemic control 10.1001/jamainternmed.2014.7345
Inconsistencies among European Union pharmaceutical regulator safety communications: A cross-country comparison 10.1371/journal.pone.0109100
A measure of care coordination? 10.1007/s11606-012-2269-0
Restricting interactions with industry to promote evidence-based prescribing 10.1001/jamainternmed.2014.2202
Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014 10.1177/0194599816689666
Association of chronic diseases and impairments with disability in older adults: A decade of change? 10.1097/MLR.0b013e318245a0e0
National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure update on publicly reported outcomes measures based on the 2010 release 10.1161/CIRCOUTCOMES.110.957613
Hospital use of observation stays: Cross-sectional study of the impact on readmission rates 10.1097/MLR.0000000000000601
Pooled analysis of rofecoxib placebo-controlled clinical trial data lessons for postmarket pharmaceutical safety surveillance 10.1001/archinternmed.2009.394
Open access platforms for sharing clinical trial data 10.1001/jama.2016.8794
Recent national trends in readmission rates after heart failure hospitalization 10.1161/CIRCHEARTFAILURE.109.885210
Strengthening medical device postmarket safety surveillance 10.1001/jamainternmed.2015.2650
Clinical research data sharing: What an open science world means for researchers involved in evidence synthesis 10.1186/s13643-016-0334-1
Sharing of clinical trial data among trialists: A cross sectional survey 10.1136/bmj.e7570
Association of admission to veterans affairs hospitals vs non-veterans affairs hospitals with mortality and readmission rates among older men hospitalized with acute myocardial infarction, heart failure, or Pneumonia 10.1001/jama.2016.0278
Payments for acute myocardial infarction episodes-of-care initiated at hospitals with and without interventional capabilities 10.1161/CIRCOUTCOMES.114.000927
Rate of asthma trial outcomes reporting on and in the published literature 10.1016/j.jaci.2014.09.019
The importance of clinical trial data sharing: Toward more open science 10.1161/CIRCOUTCOMES.112.965798
Hospital variation in risk-standardized hospital admission rates from US EDs among adults 10.1016/j.ajem.2014.03.033
Advanced access scheduling outcomes: A systematic review 10.1001/archinternmed.2011.168
The need to test strategies based on common sense 10.1001/jamainternmed.2017.1233
Trends in use of ezetimibe after the ENHANCE Trial, 2007 Through 2010 10.1001/jamainternmed.2014.3404
Effect of blinded peer review on abstract acceptance 10.1001/jama.295.14.1675
US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016 10.1177/0194599817721689
Preventive care quality of medicare accountable care organizations associations of organizational characteristics with performance 10.1097/MLR.0000000000000477
Avoidance of generic competition by Abbott Laboratories' fenofibrate franchise 10.1001/archinternmed.2012.187
Would a breakthrough therapy by any other name be as promising? 10.1001/jamainternmed.2015.5311
Declining admission rates and thirty-day readmission rates positively associated even though patients grew sicker over time 10.1377/hlthaff.2015.1614
Audit and feedback: An intervention to improve discharge summary completion 10.1002/jhm.831
Pharmaceutical company payments to physicians: Early experiences with disclosure laws in Vermont and Minnesota 10.1001/jama.297.11.1216
Trends in readmission rates for safety net hospitals and non-safety net hospitals in the era of the US Hospital Readmission Reduction Program: A retrospective time series analysis using Medicare administrative claims data from 2008 to 2015 10.1136/bmjopen-2017-016149
Challenges to biosimilar substitution - Reply 10.1001/jama.2017.11937
Statistical models and patient predictors of readmission for heart failure: A systematic review 10.1001/archinte.168.13.1371
Hospital-readmission risk — Isolating hospital effects from patient effects 10.1056/NEJMsa1702321
Availability of clinical trial data from industry-sponsored cardiovascular trials 10.1161/JAHA.116.003307
Use of preventive care by the working poor in the United States 10.1016/j.ypmed.2006.11.006
Visits for primary care services to primary care and specialty care physicians, 1999 and 2007 10.1001/archinternmed.2012.3207
A historic moment for open science: The Yale University open data access project and Medtronic 10.7326/0003-4819-158-12-201306180-00009
Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979–2015 10.1016/j.ophtha.2017.03.040
Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: Cross sectional study 10.1136/bmj.d5621
Updated estimates of pharmaceutical company payments to physicians in Vermont 10.1001/jama.2008.560
Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization a retrospective cohort 10.1161/CIRCOUTCOMES.110.959809
Making data submitted to the food and drug administration more visible 10.1001/jamainternmed.2015.6769
High incarceration rates among black men enrolled in clinical studies may compromise ability to identify disparities 10.1377/hlthaff.2013.1325
Ensuring correct interpretation of diagnostic test results 10.1001/jamainternmed.2014.165
Place of residence and outcomes of patients with heart failure: Analysis from the telemonitoring to improve heart failure outcomes trial 10.1161/CIRCOUTCOMES.113.000911
Opioid Prescribing for Opioid-Naive Patients in Emergency Departments and Other Settings: Characteristics of Prescriptions and Association With Long-Term Use 10.1016/j.annemergmed.2017.08.042
Development and Validation of an Algorithm to Identify Planned Readmissions From Claims Data 10.1002/jhm.2416
Characterizing expanded access and compassionate use programs for experimental drugs 10.1186/s13104-017-2687-5
Persistence of cardiovascular risk after rofecoxib discontinuation 10.1001/archinternmed.2010.461
The FDA unapproved drugs initiative: An observational study of the consequences for drug prices and shortages in the United States 10.18553/jmcp.2017.23.10.1066
Reporting of results in and high-impact journals 10.1001/jama.2013.285634
Evaluation of the mobile acute care of the elderly (MACE) service 10.1001/jamainternmed.2013.478
Regulatory review of novel therapeutics - Comparison of three regulatory agencies 10.1056/NEJMsa1200223
Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study 10.1136/bmj.i4189
Based on key measures, care quality for medicare enrollees at safety-net and non-safety-net hospitals was almost equal 10.1377/hlthaff.2011.1028
Characteristics of clinical studies conducted over the total product life cycle of high-risk therapeutic medical devices receiving FDA Premarket Approval in 2010 and 2011 10.1001/jama.2015.8761
Appropriateness of Collaborations between Industry and the Medical Profession: Physicians' Perceptions 10.1016/j.amjmed.2009.04.013
Predictors and outcomes of unplanned readmission to a different hospital 10.1093/intqhc/mzv082
Facts concerning duexis prescribing habits related to combination therapies: In reply 10.1001/jamainternmed.2017.2460
Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: Difference-in-differences analysis 10.1136/bmj.f264
Physician attitudes toward industry: A view across the specialties 10.1001/archsurg.2010.75
Ghostwriting: Research misconduct, plagiarism, or fool's gold? 10.1016/j.amjmed.2011.07.015
Pharmaceutical industry marketing: Understanding its impact on women's health 10.1097/OGX.0b013e31817f1585
Post-market clinical research conducted by medical device manufacturers: A cross-sectional survey 10.2147/MDER.S82964
Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): The Yale Open Data Access Medtronic Project 10.1186/s13643-017-0422-x
The authors reply 10.1056/NEJMc1208803
Editorial Comment 10.1016/j.juro.2008.10.185
Prescription-drug coupons - No such thing as a free lunch 10.1056/NEJMp1301993
Ushering in a new era of open science through data sharing: The wall must come down 10.1001/jama.2013.1299
Relationships with the drug industry: More regulation, greater transparency 10.1136/bmj.b211
Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study 10.1161/JAHA.114.001343
Use of preventive care by elderly male veterans receiving care through the veterans health administration, medicare fee-for-service, and medicare HMO plans 10.2105/AJPH.2007.114934
Variation in US hospital emergency department admission rates by clinical condition 10.1097/MLR.0000000000000261
Age-based and sex-based disparities in screening colonoscopy use among medicare beneficiaries 10.1097/MCG.0b013e31828345c8
Exposure to low-dose ionizing radiation from medical imaging procedures 10.1056/NEJMoa0901249
Mis-SHAPEing public health policy 10.1161/CIRCOUTCOMES.109.890715
Hospital discharge and the transition home for poor patients: "I knew i couldn't do what they were asking me" 10.1007/s11606-013-2698-4
A better pain plan 10.1001/jamainternmed.2015.97
Economic Evaluation of a Comprehensive Teenage Pregnancy Prevention Program. Pilot Program 10.1016/j.amepre.2009.08.014
Compliance with prospective trial registration guidance remained low in high-impact journals and has implications for primary end point reporting 10.1016/j.jclinepi.2016.01.017
Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection 10.1016/j.jaip.2017.07.034
Transfer rates from nonprocedure hospitals after initial admission and outcomes among elderly patients with acute myocardial infarction 10.1001/jamainternmed.2013.11944
Use of fibrates in the United States and Canada 10.1001/jama.2011.353
Publication and reporting of clinical trial results: Cross sectional analysis across academic medical centers 10.1136/bmj.i637
Recent trends in chronic disease, impairment and disability among older adults in the United States 10.1186/1471-2318-11-47
Time to publication among completed clinical trials 10.1001/jamainternmed.2013.136
Intensive treatment and severe hypoglycemia among adults with type 2 diabetes 10.1001/jamainternmed.2016.2275
The updated AMSA scorecard of conflict-of-interest policies: A survey of U.S. medical schools 10.1186/s12909-016-0725-y
Study of neurontin: Titrate to effect, profile of safety (STEPS) trial - A narrative account of a gabapentin seeding trial 10.1001/archinternmed.2011.241
How do orthopaedic devices change after their initial FDA premarket approval? 10.1007/s11999-015-4634-x
A random effects multinomial logit analysis of using medicare and Va healthcare among veterans with dementia 10.1080/01621424.2010.493771
Revisiting essure-toward safe and effective sterilization 10.1056/NEJMp1510514
Regional Variation in Cardiac Catheterization Appropriateness and Baseline Risk After Acute Myocardial Infarction 10.1016/j.jacc.2007.10.039
Physician clinical management strategies and reasoning: A cross-sectional survey using clinical vignettes of eight common medical admissions 10.1186/1472-6963-14-176
The use and misuse of thrombolytic therapy within the veterans health administration 10.1097/MLR.0b013e3182294092
Long-term risk for device-related complications and reoperations after implantable cardioverter-defibrillator implantation: An observational cohort study 10.7326/M15-2732
Quality of Care in the United States Territories, 1999-2012 10.1097/MLR.0000000000000797
Determinants of cardiac catheterization use in older medicare patients with acute myocardial infarction 10.1161/CIRCOUTCOMES.109.858456
National quality assessment evaluating spironolactone use during hospitalization for acute myocardial infarction (AMI) in China: China Patient-centered Evaluation Assessment of Cardiac Events (PEACE)-Retrospective AMI Study, 2001, 2006, and 2011 10.1161/JAHA.114.001718
A model for dissemination and independent analysis of industry data 10.1001/jama.2011.1459
Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012 10.1001/jama.2013.282034
Trends in length of stay and short-term outcomes among medicare patients hospitalized for heart failure, 1993-2006 10.1001/jama.2010.748
Frequency and importance of incomplete screening fetal anatomic sonography in pregnancy 10.7863/ultra.16.01084
Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada 10.1016/j.ahj.2014.01.014
The authors reply 10.1056/NEJMc1705868
Response to letter regarding article, "recent national trends in readmission rates after heart failure hospitalization" 10.1161/CIRCHEARTFAILURE.110.952895
On Ghosts and Other Unwelcome Guests 10.1007/s11606-015-3400-9
Data desert for inferior vena caval filters: Limited evidence, supervision, and research 10.1001/jamacardio.2016.3764
Correlation of inpatient and outpatient measures of stroke care quality within veterans health administration hospitals 10.1161/STROKEAHA.110.611913
Characterisation of trials where marketing purposes have been influential in study design: A descriptive study 10.1186/s13063-015-1107-1
Industry support of physician education in the USA 10.1136/jech-2015-206592
Reduction in acute myocardial infarction mortality in the United States: Risk-standardized mortality rates from 1995-2006 10.1001/jama.2009.1178
Discharge disposition disagreements and re-admission risk among older adults: A retrospective cohort study 10.1136/bmjopen-2012-001646
Impact of state laws that extend eligibility for parents' health insurance coverage to young adults 10.1542/peds.2011-1505
FDA Policy and Cardiovascular Medicine 10.1161/CIRCULATIONAHA.114.010295
Association of changing hospital readmission rates with mortality rates after hospital discharge 10.1001/jama.2017.8444
Having Their Cake and Eating It Too: Physician Skepticism of the Open Payments Program 10.1080/15265161.2017.1313340
Financial Ties Between Emergency Physicians and Industry: Insights From Open Payments Data 10.1016/j.annemergmed.2016.01.014
A better pain plan 10.1001/jamainternmed.2015.102
Pediatric screening urinalysis: A difference-indifferences analysis of how a 2007 change in guidelines impacted use 10.1186/1471-2431-14-260
Postmarket Modifications of High-Risk Therapeutic Devices in Otolaryngology Cleared by the US Food and Drug Administration 10.1177/0194599815587508
Trial-results reporting and academic medical centers 10.1056/NEJMc1505965
Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: Implications for regionalization 10.1001/archinternmed.2009.538
Hospital remoteness and thirty-day mortality from three serious conditions 10.1377/hlthaff.27.6.1707
State medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning 10.1377/hlthaff.2011.1068
Regional-level correlations in inappropriate imaging rates for prostate and breast cancers: Potential implications for the Choosing Wisely campaign 10.1001/jamaoncol.2015.37
Factors Associated with Refugee Acute Healthcare Utilization in Southern Connecticut 10.1007/s10903-017-0574-8
The US food and drug administration 515 program initiative: Addressing the evidence gap for widely used, high-risk cardiovascular devices? 10.1001/jamacardio.2016.0002
Decision-making and cancer screening: A qualitative study of older adults with multiple chronic conditions 10.1016/j.jgo.2014.12.001
Population of us practicing psychiatrists declined, 2003-13, which may help explain poor access to mental health care 10.1377/hlthaff.2015.1643
"Transparency reports" on industry payments to physicians and teaching hospitals 10.1001/jama.2012.211
Doctors and healthcare reform: A duty to understand? 10.1136/postgradmedj-2014-132689
The importance of independent evaluation 10.1001/jamainternmed.2017.2719
Through the looking glass: Evaluating the dissemination of research in cardiology 10.1093/eurheartj/ehs160
Skilled nursing facility referral and hospital readmission rates after heart failure or myocardial infarction 10.1016/j.amjmed.2011.06.011
Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction 10.1001/jama.2010.409
Association between hospital penalty status under the hospital readmission reduction program and readmission rates for target and nontarget conditions 10.1001/jama.2016.18533
Poorly cited articles in peer-reviewed cardiovascular journals from 1997 to 2007: Analysis of 5-year citation rates 10.1161/CIRCULATIONAHA.114.015080
The cost of breast cancer screening in the medicare population 10.1001/jamainternmed.2013.1397
Hospital-based, acute care use among patients within 30 days of discharge after coronary artery bypass surgery 10.1016/j.athoracsur.2013.03.091
Use of medicare and department of veterans affairs health care by veterans with dementia: A longitudinal analysis 10.1111/j.1532-5415.2009.02405.x
Cardiac Certificate of Need regulations and the availability and use of revascularization services 10.1016/j.ahj.2007.06.031
Comparison of the US and Canadian Health Care Systems: A tale of 2 Mount Sinai's 10.1001/jama.300.16.1934
Impact of laboratory cost display on resident attitudes and knowledge about costs 10.1136/postgradmedj-2015-133851
Physician and other healthcare personnel responses to hospital stroke quality of care performance feedback: A qualitative study 10.1136/bmjqs-2015-004197
Trial publication after registration in A cross-sectional analysis 10.1371/journal.pmed.1000144
Is P4P really FFS? 10.1001/jama.298.15.1797
Efficacy and safety concerns are important reasons why the FDA requires multiple reviews before approval of new drugs 10.1377/hlthaff.2014.1160
Postmarket safety events among novel therapeutics approved by the US food and drug administration between 2001 and 2010 10.1001/jama.2017.5150
Comparative effectiveness of generic atorvastatin and lipitor® in patients hospitalized with an acute coronary syndrome 10.1161/JAHA.116.003350
Global drug safety insights from Taiwan 10.1001/jamainternmed.2015.5402
Publication of clinical studies supporting FDA premarket approval for high-risk cardiovascular devices between 2011 and 2013: A cross-sectional study 10.1001/jamainternmed.2015.8590
Who is missing from the measures? Trends in the proportion and treatment of patients potentially excluded from publicly reported quality measures 10.1016/j.ahj.2010.06.046
Regulatory watch: Characterizing the US FDA's approach to promoting transformative innovation 10.1038/nrd4734
Making electronic health records work better for patient care 10.1001/jamainternmed.2016.0219
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia 10.1001/jama.2012.216476
The cost implications of prostate cancer screening in the Medicare population 10.1002/cncr.28373
Restricting interactions with industry to promote evidence-based prescribing 10.1001/jamainternmed.2014.1862
Use of health care services by lower-income and higher-income uninsured adults 10.1001/jama.295.17.2027
Sea change in open science and data sharing: Leadership by industry 10.1161/CIRCOUTCOMES.114.001166
Risk-standardized acute admission rates among patients with diabetes and heart failure as a measure of quality of accountable care organizations rationale, methods, and early results 10.1097/MLR.0000000000000518
Association of the FDA Amendment Act with trial registration, publication, and outcome reporting 10.1186/s13063-017-2068-3
Reporting hospital quality: The authors reply 10.1377/hlthaff.2011.0101
For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery 10.1016/j.surg.2013.12.009
Hospital-based, acute care after ambulatory surgery center discharge 10.1016/j.surg.2013.12.008
Generic drug approvals since the 1984 hatch-waxman act 10.1001/jamainternmed.2016.3411
Switching from rosiglitazone: Thinking outside the class 10.1001/jama.2011.193
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure 10.1161/CIRCOUTCOMES.108.802686
Policy research: Using evidence to improve healthcare delivery systems 10.1161/CIRCULATIONAHA.107.729855
Impact of the 2008 US preventive services task force recommendation to discontinue prostate cancer screening among male medicare beneficiaries 10.1001/archinternmed.2012.3726
Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study 10.1002/pds.3910
Response to Letter Regarding Article, "poorly Cited Articles in Peer-Reviewed Cardiovascular Journals from 1997 to 2007: Analysis of 5-Year Citation Rates" 10.1161/CIRCULATIONAHA.115.018777
Conflicts of interest, authorship, and disclosures in industry-related scientific publications [4] 10.4065/mcp.2009.0744
High prices for drugs with generic alternatives: The curious case of Duexis 10.1001/jamainternmed.2016.8423
Impact of hospitalization for acute myocardial infarction on adherence to statins among older adults 10.1161/CIRCOUTCOMES.115.002418
Predictors of clinical trial data sharing: Exploratory analysis of a cross-sectional survey 10.1186/1745-6215-15-384
Inclusion of demographic-specific information in studies supporting US Food & Drug Administration approval of high-risk medical devices 10.1001/jamainternmed.2017.3148
Randomized clinical trials and observational studies are more often alike than unlike 10.1001/jamainternmed.2014.3366
Why the Open Payments Program Is Likely to Provide Systematic and Transparent Data on Financial Relationships with Industry 10.1016/j.amjmed.2016.01.051
Promoting transparency in pharmaceutical industry-sponsored research 10.2105/AJPH.2011.300187
Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014 10.1177/0194599816684094
Hospital volume and 30-day mortality for three common medical conditions 10.1056/NEJMsa0907130
Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals 10.1161/CIRCULATIONAHA.107.709220
Tamiflu: 14 Flu seasons and still questions 10.1136/bmj.f547
Hospital-Based Acute Care After Total Hip and Knee Arthroplasty: Implications for Quality Measurement 10.1016/j.arth.2015.10.019
Use of hospital-based acute care among patients recently discharged from the hospital 10.1001/jama.2012.216219
Coronary artery bypass graft contemporary heart surgery center performance in China 10.1161/CIRCOUTCOMES.111.962365
State-sponsored public reporting of hospital quality: Results are hard to find and lack uniformity 10.1377/hlthaff.2010.0564
Hospital readmission performance and patterns of readmission: Retrospective cohort study of Medicare admissions 10.1136/bmj.f6571
Association of physician specialty and medical therapy for benign prostatic hyperplasia 10.1097/MLR.0000000000000078
The rising price of naloxone-risks to efforts to stem overdose deaths 10.1056/NEJMp1609578
Impact of drug policy on regional trends in ezetimibe use 10.1161/CIRCOUTCOMES.114.001023
Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia 10.1001/jama.2013.333
Appropriate proton pump inhibitor use among older adults: A retrospective chart review 10.1016/j.amjopharm.2008.12.001
Dual use of veterans affairs services and use of recommended ambulatory care 10.1097/MLR.0b013e31815b9db3
Moving forward from rhBMP-2: Open science and data sharing 10.1097/BRS.0000000000000256
Older women with localized breast cancer: Costs and survival rates increased across two time periods 10.1377/hlthaff.2014.1119
National trends in stroke after acute myocardial infarction among Medicare patients in the United States: 1999 to 2010 10.1016/j.ahj.2014.06.011
Influence of patients' socioeconomic status on clinical management decisions: A qualitative study 10.1370/afm.749
The physical activity contract - Tailored to promote physical activity in a geriatric outpatient setting: A pilot study 10.1111/j.1532-5415.2010.02751.x
Health and health care use among individuals at risk to lose health insurance with repeal of the affordable care act 10.1001/jamainternmed.2016.954
Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013 10.2337/dc16-0985
The relationship between systolic blood pressure on admission and mortality in older patients with heart failure 10.1093/eurjhf/hfp195
Differences in Colonoscopy Quality among Facilities: Development of a Post-Colonoscopy Risk-Standardized Rate of Unplanned Hospital Visits 10.1053/j.gastro.2015.09.009
Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing 10.1371/journal.pone.0023336
Development and use of an administrative claims measure for profiling hospital-wide performance on 30-day unplanned readmission 10.7326/M13-3000
Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: A cross-sectional study 10.1111/bcp.12643
The importance of population-based performance measures 10.1111/j.1475-6773.2006.00693.x
Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010 10.1001/jama.2014.6316
Innovation, risk, and patient empowerment the FDA-mandated withdrawal of 23andMe's personal genome service 10.1001/jama.2014.148
Beyond insurance coverage: Usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey 10.1016/j.ahj.2010.04.013
Description of a research-based health activism curriculum for medical students 10.1111/j.1525-1497.2006.00608.x
Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals 10.1186/s13063-016-1322-4
Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: Systematic review 10.1136/bmj.j1680
Withdrawal of personal genome service - Reply 10.1001/jama.2014.5584
Publication of NIH funded trials registered in Cross sectional analysis 10.1136/bmj.d7292
Clinical trial registration, reporting, publication and FDAAA compliance: A cross-sectional analysis and ranking of new drugs approved by the FDA in 2012 10.1136/bmjopen-2015-009758
Variation in the Diagnosis of Aspiration Pneumonia and Association with Hospital Pneumonia Outcomes 10.1513/AnnalsATS.201709-728OC
Overview and experience of the YODA Project with clinical trial data sharing after 5 years 10.1038/sdata.2018.268
Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011 10.1161/JAHA.116.005285
For transparency and accountability more is better 10.1038/s41562-018-0300-0
Bringing Vioxx back to market 10.1136/bmj.k242
A Nationwide Assessment of the Association of Smoking Bans and Cigarette Taxes with Hospitalizations for Acute Myocardial Infarction, Heart Failure, and Pneumonia 10.1177/1077558716668646
Older drugs with infantile evidence: The illustrative example of loop diuretics 10.1093/ehjqcco/qcy012
Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators 10.1002/pds.4565
Coverage of novel therapeutic agents by medicare prescription drug plans following FDA approval 10.18553/jmcp.2018.24.12.1230
Publication and dissemination of results in clinical trials of neurology 10.1001/jamaneurol.2018.0674
Can machine learning complement traditional medical device surveillance? A case study of dualchamber implantable cardioverter–defibrillators 10.2147/MDER.S138158
Evidence supporting FDA approval and CMS national coverage determinations for novel medical products, 2005 through 2016: A cross-sectional study 10.1097/MD.0000000000012715
The US Food and Drug Administration’s expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation 10.1177/1740774518770657
Measuring clinical trial transparency: An empirical analysis of newly approved drugs and large pharmaceutical companies 10.1136/bmjopen-2017-017917
Adherence to the International Committee of Medical Journal Editors' (ICMJE) prospective registration policy and implications for outcome integrity: A cross-sectional analysis of trials published in high-impact specialty society journals 10.1186/s13063-018-2825-y
Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors 10.1634/theoncologist.2017-0673
Medicare beneficiary out-of-pocket costs for generic cardiovascular medications available through $4 generic drug discount programs 10.7326/M18-0965
Early experiences with journal data sharing policies: A survey of published clinical trial investigators 10.7326/M18-0723
Will research preprints improve healthcare for patients? 10.1136/bmj.k3628
Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trials 10.1001/jamaoncol.2018.0798
Fulfilling the promise of unique device identifiers 10.7326/M18-0526
New and incremental FDA black box warnings from 2008 to 2015 10.1080/14740338.2018.1415323
Affordability and availability of off-patent drugs in the United States - The case for importing from abroad: Observational study 10.1136/bmj.k831
Research, regulatory, and clinical decision-making: the importance of scientific integrity 10.1016/j.jclinepi.2017.08.021
US drug marketing: how does promotion correspond with health value? 10.1136/bmj.j1855
Statewide Inferior Vena Cava Filter Placement, Complications, and Retrievals 10.1097/MLR.0000000000000867
US federal government efforts to improve clinical trial transparency with expanded trial registries and open data sharing 10.1001/journalofethics.2015.17.12.pfor1-1512
Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines 10.1007/s11606-017-4274-9
Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: Cross sectional analysis 10.1136/bmj.k2031
Coordinating Clinical Trials to Confirm Drug Safety and Efficacy - Resolving Uncertainty 10.1001/jamainternmed.2018.6037
Merits of Data Sharing: The Digitalis Investigation Group Trial 10.1016/j.jacc.2017.07.786
Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis 10.1007/s11606-018-4779-x
Data Sharing and Cardiology: Platforms and Possibilities 10.1016/j.jacc.2017.10.037
Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study 10.1136/bmjopen-2017-018587
Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study 10.1002/ijc.31061
National Prescribing Trends for High-Risk Anticholinergic Medications in Older Adults 10.1111/jgs.15357
Defining Multiple Chronic Conditions for Quality Measurement 10.1097/MLR.0000000000000853
Clinical Trials - We Get What We Pay for 10.1001/jamainternmed.2018.3930
The early impact of Medicaid expansion on uninsured patients undergoing emergency general surgery 10.1016/j.jss.2018.06.037
Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: Retrospective cohort study 10.1136/bmj.k2833
Triage, copayments, and emergency department visits 10.1001/jamainternmed.2016.0882
Blueprint for transparency at the U.S. food and drug administration: Recommendations to advance the development of safe and effective medical products 10.1177/1073110517750615
Alirocumab's price reduction implications of a paradigm shift toward cost-effective pricing 10.1161/CIRCULATIONAHA.118.036069
Medicare spending and potential savings on brand-name drugs with available generic substitutes excluded by 2 large pharmacy benefit managers, 2012 through 2015 10.1001/jamainternmed.2017.8016
Physician denial of inappropriate patient requests?what if i say no? 10.1001/jamainternmed.2017.7367
High Costs of FDA approval for formerly unapproved marketed drugs 10.1001/jama.2017.16481
The Open Translational Science in Schizophrenia (OPTICS) project: An open-science project bringing together Janssen clinical trial and NIMH data 10.1038/s41537-018-0055-7
Patterns and predictors of off-label prescription of psychiatric drugs 10.1371/journal.pone.0198363
Association of Inferior Vena Cava Filter Use with Mortality Rates in Older Adults with Acute Pulmonary Embolism 10.1001/jamainternmed.2018.5287
Making Data Submitted to the Food and Drug Administration More Visible 10.1001/jamainternmed.2015.6773
State-Level Population Estimates of Individuals Subject to and Not Meeting Proposed Medicaid Work Requirements 10.1001/jamainternmed.2018.4196
Medicare formulary coverage restrictions for prescription opioids, 2006 to 2015 10.7326/M17-1823
Review of clinical trial settings of drugs commonly used in primary care and approved between 2005 and 2012 10.1007/s11606-018-4486-7
Emergency Department Volume and Outcomes for Patients After Chest Pain Assessment 10.1161/CIRCOUTCOMES.118.004683
Age differences in hospital mortality for acute myocardial infarction: Implications for hospital profiling 10.7326/M16-2871
Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: A retrospective cohort study 11 Medical and Health Sciences 1117 Public Health and Health Services 10.1186/s13063-018-2957-0
The Impact of Off-Patent Drug Acquisitions on Prices 10.1007/s11606-018-4372-3
Pediatric exclusivity and regulatory authority implications of Amgen v HHS 10.1001/jama.2017.16477
Network optimization and the continuity of physicians in medicaid managed care 10.1377/hlthaff.2017.1410
The US Food and Drug Administration’s expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements 10.1177/1740774518770648
Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts 10.1001/jama.2017.21897
Accurate estimation of cardiovascular risk in a non-diabetic adult: Detecting and correcting the error in the reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial population 10.1136/bmjopen-2018-021685
Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis 10.1002/cpt.1038
Clinical trial evidence supporting FDA approval of drugs granted breakthrough therapy designation 10.1001/jama.2018.7619
Therapeutic substitution-Should it be systematic or automatic? 10.1001/jamainternmed.2016.2271
Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: A meta-epidemiological study 10.1186/s12916-018-1023-9
Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016 10.1210/jc.2018-02197
Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents Over Three Decades, 1995-2017: Cross-Sectional Analysis 10.1101/19007047
Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics 10.1007/s11606-019-05432-6
Modernizing the FDA’s 510(k) Pathway 10.1056/NEJMp1908654
Aggregating Multiple Real-World Data Sources using a Patient-Centered Health Data Sharing Platform: an 8-week Cohort Study among Patients Undergoing Bariatric Surgery or Catheter Ablation of Atrial Fibrillation 10.1101/19010348
Impact of left ventricular assist devices and heart transplant on acute myocardial infarction and heart failure mortality and readmission measures 10.1101/19011213
Systematic overview of Freedom of Information Act requests to the Department of Health and Human Services from 2008 to 2017 10.1186/s41073-019-0086-2
Impact of left ventricular assist devices and heart transplants on acute myocardial infarction and heart failure mortality and readmission measures 10.1371/journal.pone.0230734
Evaluation of the Anticipated Burden of COVID-19 on Hospital-Based Healthcare Services Across the United States 10.1101/2020.04.01.20050492
Commentary on Bertagnolli et al.: Leveraging electronic health record data for clinical trials—a brave new world 10.1177/1740774520913850
Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform 10.1038/s41746-020-0265-z
Clinical Evidence Supporting FDA Clearance of First-of-a-Kind Therapeutic Devices via the De Novo Pathway Between 2011 and 2019 10.1101/2020.04.23.20077164
Consistency of trial reporting between and corresponding publications: one decade after FDAAA 10.1186/s13063-020-04603-9
Early experience with the FDA’s Breakthrough Devices program 10.1038/s41587-020-0636-7
Submissions from the SPRINT Data Analysis Challenge on clinical risk prediction: A cross-sectional evaluation 10.1136/bmjopen-2018-025936
Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews 10.1177/1740774519887148
On the Need for (Only) High-Quality Clinical Practice Guidelines 10.1001/jamainternmed.2018.7471
The Bleeding Edge: Documenting Innovation and Injury in the Medical Device Industry 10.1001/jama.2019.8147
Digital medicine systems: An evergreening strategy or an advance in medication management? 10.1136/bmjebm-2019-111265
U.S. prescribing trends of fentanyl, opioids, and other pain medications in outpatient and emergency department visits from 2006 to 2015 10.1016/j.ypmed.2019.03.022
Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016 10.1001/jamanetworkopen.2019.8325
Hospital remoteness and thirty-day mortality from three serious conditions (Health Affairs (2008) (1707-1717)) 10.1377/hlthaff.28.3.922
Medicare Prescription Drug Plan Coverage of Hormone Therapies Used by Transgender Individuals 10.1089/lgbt.2019.0306
Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: A cross-sectional analysis 10.1186/s12916-019-1344-3
The Supreme Court's Latest Ruling on Drug Liability and its Implications for Future Failure-to-Warn Litigation 10.1177/1073110519897793
Adoption of New Glucose-Lowering Medications in the U.S. - The Case of SGLT2 Inhibitors: Nationwide Cohort Study 10.1089/dia.2019.0213
Conflicts of Interest Among Authors of Published Cannabidiol Articles, 2014-2019 10.7326/M19-3650
Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump with In-Hospital Mortality and Major Bleeding among Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock 10.1001/jama.2020.0254
Communicating, and Justifying, Nonefficacy Benefits for New Drugs Approved on the Basis of Noninferiority Trials 10.1001/jamainternmed.2018.8019
Risk of Readmission After Discharge From Skilled Nursing Facilities Following Heart Failure Hospitalization: A Retrospective Cohort Study 10.1016/j.jamda.2019.01.135
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults 10.1111/jgs.15966
Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates 10.1161/CIRCULATIONAHA.119.040580
Accidental drug overdose deaths in Connecticut, 2012–2018: The rise of polysubstance detection? 10.1016/j.drugalcdep.2019.107671
Home Health Care After Skilled Nursing Facility Discharge Following Heart Failure Hospitalization 10.1111/jgs.16179
Evaluation of confounding in epidemiologic studies assessing alcohol consumption on the risk of ischemic heart disease 10.1186/s12874-020-0914-6
The Human Costs of Medicare Fraud and Abuse 10.1001/jamainternmed.2019.5004
Association between Insurance Status and Access to Hospital Care in Emergency Department Disposition 10.1001/jamainternmed.2019.0037
Age-treatment subgroup analyses in Cochrane intervention reviews: A meta-epidemiological study 10.1186/s12916-019-1420-8
Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10-Year Assessment 10.1161/JAHA.119.012065
Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolism 10.1016/j.thromres.2019.12.020
Use of Mechanical Cardiopulmonary Resuscitation Devices for Out-of-Hospital Cardiac Arrest, 2010-2016 10.1001/jamanetworkopen.2019.13298
Medicare part D spending on single-enantiomer drugs versus their racemic precursors 10.7326/M19-1085
Kept in the dark: Scotland rejects "sunshine" legislation 10.1136/bmj.l1379
Updating insights into rosiglitazone and cardiovascular risk through shared data: Individual patient and summary level meta-analyses 10.1136/bmj.l7078
Availability of Grocery Delivery to Food Deserts in States Participating in the Online Purchase Pilot 10.1001/jamanetworkopen.2019.16444
Confidentiality Orders and Public Interest in Drug and Medical Device Litigation 10.1001/jamainternmed.2019.5161
Association between Industry Payments to Physicians and Gabapentinoid Prescribing 10.1001/jamainternmed.2019.1082
Gout Treatment in the USA from 2009 to 2016: A Repeated Cross-sectional Analysis 10.1007/s11606-020-05942-8
Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on 10.1001/jamapsychiatry.2020.1167
Assessment of Preprint Policies of Top-Ranked Clinical Journals 10.1001/jamanetworkopen.2020.11127
Evidence Supporting US Food and Drug Administration Drug Safety Communications 10.1001/jamainternmed.2019.3065
Association of Racial and Socioeconomic Disparities With Outcomes Among Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, and Pneumonia: An Analysis of Within- and Between-Hospital Variation 10.1001/jamanetworkopen.2018.2044
Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017 10.18553/jmcp.2020.26.4.562
Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data 10.1161/JAHA.119.013606
The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement: Explanation and elaboration 10.7326/M18-3668
The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement 10.7326/M18-3667
Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments 10.1001/jamanetworkopen.2019.3410
Time for NIH to lead on data sharing 10.1126/science.aba4456
Vibration of effects in epidemiologic studies of alcohol consumption and breast cancer risk 10.1093/ije/dyz271
Weighing the harms and benefits of using statins for primary prevention: Raising the risk threshold 10.7326/M18-3066
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm 10.1007/s10754-020-09282-2
Noninferiority Designed Cardiovascular Trials in Highest-Impact Journals: Main Findings, Methodological Quality, and Time Trends 10.1161/CIRCULATIONAHA.119.040214
Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017 10.1001/jamanetworkopen.2020.3284
Association of statewide certificate of need regulations with percutaneous coronary intervention appropriateness and outcomes 10.1161/JAHA.118.010373
Medicare prescription drug plan formulary restrictions after postmarket FDA black box warnings 10.18553/jmcp.2019.25.11.1201
Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: Cross sectional descriptive study and pilot of a tool to improve company practices 10.1136/bmj.l4217
Assessment of Health Status and Barriers to Employment among Medicaid Beneficiaries Not Meeting Work Requirements after Accounting for State Medical Frailty Exemptions 10.1001/jamainternmed.2020.1039
Exploring crowdfunding campaigns for abortion services 10.1016/j.contraception.2020.02.008
Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration 10.1001/jamanetworkopen.2019.13029
Age of Data at the Time of Publication of Contemporary Clinical Trials 10.1001/jamanetworkopen.2018.1065
Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008–2015 10.1111/1468-0009.12403
Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence 10.1001/jamanetworkopen.2019.12869
Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017 10.1007/s11606-018-4752-8
Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials 10.1016/j.ahj.2019.09.002
Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing 10.1001/jamanetworkopen.2019.1340
Biomarkers as Surrogate Endpoints: Ongoing Opportunities for Validation 10.1177/1073110519876170
Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment Agencies 10.1007/s11606-019-05149-6
Medicare beneficiaries' out-of-pocket costs for commonly used generic drugs, 2009-2017 10.37765/ajmc.2020.42635
Disagreements Within the US Food and Drug Administration Regarding Approval of Novel Therapeutic Agents, 2011-2015 10.1001/jamanetworkopen.2020.9498
Clinical Trial Evidence for the Real World 10.1001/jamainternmed.2019.1500
Association of Pharmaceutical Manufacturer Payments to Physicians and Prescribing Dosage of Opioids 10.1007/s11606-019-04897-9
Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs 10.1001/jamanetworkopen.2018.0283
Generic Drugs in the United States: Policies to Address Pricing and Competition 10.1002/cpt.1314
Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trials 10.1177/1740774520949157
U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018 10.1101/2020.08.31.20184184
Publishing at any cost: a cross-sectional study of the amount that medical researchers spend on open-access publishing each year 10.1101/2020.12.16.20247643
Registration, Publication, and Outcome Reporting among Pivotal Clinical Trials that Supported FDA Approval of High-Risk Medical Devices Before and After FDAAA 10.1101/2021.02.28.21252619
Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020 10.1007/s11606-021-06670-3
Medicare’s New Device-Coverage Pathway — Breakthrough or Breakdown? 10.1056/NEJMp2101874
Unplanned Hospital Visits after Ambulatory Surgical Care 10.1101/2021.03.10.21249910
Accuracy of Computable Phenotyping Approaches for SARS-CoV-2 Infection and COVID-19 Hospitalizations from the Electronic Health Record 10.1101/2021.03.16.21253770
Leveraging Open Science to Accelerate Research 10.1056/NEJMp2034518
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009–2018 10.1177/17407745211005044
Direct-to-consumer personal genomic tests need better regulation 10.1038/s41591-021-01368-9
Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use 10.1007/s12020-021-02779-x
Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation 10.1177/17407745211030683
Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials 10.1101/2021.07.16.21260509
Characteristics of available studies and dissemination of research using major clinical data sharing platforms 10.1177/17407745211038524
Clinical Trial Data Sharing: A Cross-Sectional Study of Outcomes Associated with Two NIH Models 10.1101/2021.09.10.21263404
Kristin Ray
Ray Kristin
ORCID: 0000-0003-3817-1449
Supply and utilization of pediatric subspecialists in the United States 10.1542/peds.2013-3466
Family Perspectives on Telemedicine for Pediatric Subspecialty Care 10.1089/tmj.2016.0236
Disparities in time spent seeking medical care in the United States 10.1001/jamainternmed.2015.4468
Optimizing telehealth strategies for subspecialty care: Recommendations from rural pediatricians 10.1089/tmj.2014.0186
Hospitalization of rural and urban infants during the first year of life 10.1542/peds.2012-0020
Premature infants born to adolescent mothers: Health care utilization after initial discharge 10.1016/j.acap.2010.07.005
Family Perspectives on High-Quality Pediatric Subspecialty Referrals 10.1016/j.acap.2016.05.147
Trends in access to primary care for children in the United States, 2002-2013 10.1001/jamapediatrics.2016.0985
Practicing pediatrics with the meter running 10.1542/pir.30-1-22
Clinician attitudes toward adoption of pediatric emergency telemedicine in rural hospitals 10.1097/PEC.0000000000000583
The opportunity costs of informal elder-care in the United States: New estimates from the American Time Use Survey 10.1111/1475-6773.12238
Use of Adult-Trained Medical Subspecialists by Children Seeking Medical Subspecialty Care 10.1016/j.jpeds.2016.05.073
Trends in visits to specialist physicians involving nurse practitioners and physician assistants, 2001 to 2013 10.1001/jamainternmed.2017.1630
Strengthening stakeholder-engaged research and research on stakeholder engagement 10.2217/cer-2016-0096
Access to High Pediatric-Readiness Emergency Care in the United States 10.1016/j.jpeds.2017.10.074
Geographic Access to International Board-Certified Lactation Consultants in Pennsylvania 10.1177/0890334418768458
Connected Subspecialty Care: Applying Telehealth Strategies to Specific Referral Barriers 10.1016/j.acap.2019.08.002
The Use of and Experiences With Telelactation Among Rural Breastfeeding Mothers: Secondary Analysis of a Randomized Controlled Trial (Preprint) 10.2196/preprints.13967
The Use of and Experiences With Telelactation Among Rural Breastfeeding Mothers: Secondary Analysis of a Randomized Controlled Trial 10.2196/13967
Feasibility and Effectiveness of Telelactation Among Rural Breastfeeding Women 10.1016/j.acap.2019.10.008
Validation of use of billing codes for identifying telemedicine encounters in administrative data 10.1186/s12913-019-4753-2
Advancing the Dissemination of Innovations in Pediatric Health Care Delivery 10.1016/j.acap.2019.12.001
Transgender Youth's Disclosure of Gender Identity to Providers Outside of Specialized Gender Centers 10.1016/j.jadohealth.2019.12.010
Parent Perspectives on Family-Centered Pediatric Electronic Consultations: Qualitative Study 10.2196/16954
Parent Perspectives on Family-Centered Pediatric Electronic Consultations: Qualitative Study (Preprint) 10.2196/preprints.16954
Practice-Level Variation in Telemedicine Use in a Pediatric Primary Care Network During the COVID-19 Pandemic: Retrospective Analysis and Survey Study 10.2196/24345
Practice-Level Variation in Telemedicine Use in a Pediatric Primary Care Network During the COVID-19 Pandemic: Retrospective Analysis and Survey Study (Preprint) 10.2196/preprints.24345
Optimizing e-Consultations to Adolescent Medicine Specialists: Qualitative Synthesis of Feedback From User-Centered Design 10.2196/25568
Optimizing e-Consultations to Adolescent Medicine Specialists: Qualitative Synthesis of Feedback From User-Centered Design (Preprint) 10.2196/preprints.25568
Ateev Mehrotra
Mehrotra Ateev
ORCID: 0000-0003-2223-1582
Walk-in clinics versus physician offices and emergency rooms for urgent care and chronic disease management 10.1002/14651858.CD011774.pub2
Utilization of telemedicine among rural medicare beneficiaries 10.1001/jama.2016.2186
Incorrect Conclusions Concerning Antibiotics and Asthma Exacerbation: In reply 10.1001/jamainternmed.2017.0113
Congestive heart failure disease management in Medicare-managed care 10.1016/j.ahj.2007.07.024
High-price and low-price physician practices do not differ significantly on care quality or efficiency 10.1377/hlthaff.2016.1266
Public reporting of colonoscopy quality is associated with an increase in endoscopist adenoma detection rate 10.1016/j.gie.2014.12.058
The impact of exclusion criteria on a physician's adenoma detection rate 10.1016/j.gie.2014.12.056
Implementing open-access scheduling of visits in primary care practices: A cautionary tale 10.7326/0003-4819-148-12-200806170-00004
Improving value in health care - Against the annual physical 10.1056/NEJMp1507485
The Relative Importance of Post-Acute Care and Readmissions for Post-Discharge Spending 10.1111/1475-6773.12448
Retail clinics, primary care physicians, and emergency departments: A comparison of patients' visits 10.1377/hlthaff.27.5.1272
Trends in Pediatric Primary Care Visits among Commercially Insured US Children, 2008-2016 10.1001/jamapediatrics.2019.5509
Ensuring excellence in centers of excellence programs 10.1097/SLA.0000000000001071
Feasibility and Effectiveness of Telelactation Among Rural Breastfeeding Women 10.1016/j.acap.2019.10.008
Antibiotic prescribing during pediatric direct-to-consumer telemedicine visits 10.1542/peds.2018-2491
Maryland's Hospital Global budget program 10.1001/jama.2018.14370
Evaluation of centers of excellence program for knee and hip replacement 10.1097/MLR.0b013e3182699407
The growth of retail clinics and the medical home: Two trends in concert or in conflict? 10.1377/hlthaff.2010.0089
Consumers' and providers' responses to public cost reports, and how to raise the likelihood of achieving desired results 10.1377/hlthaff.2011.1181
Paying patients to switch: Impact of a rewards program on choice of providers, prices, and utilization 10.1377/hlthaff.2018.05068
The volume-quality relationship in antibiotic prescribing: When more isn't better 10.1177/0046958015571130
Trends in Telemedicine Use in a Large Commercially Insured Population, 2005-2017 10.1001/jama.2018.12354
Drowning in a sea of paperwork: Toward a more patient-centered billing system in the United States 10.7326/M15-2283
The growth of retail clinics in vaccination delivery in the U.S. 10.1016/j.amepre.2012.02.024
On call at the mall: A mixed methods study of U.S. medical malls 10.1186/1472-6963-13-471
Physicians with the least experience have higher cost profiles than do physicians with the most experience 10.1377/hlthaff.2011.0252
Declining use of primary care among commercially insured adults in the United States, 2008 –2016 10.7326/M19-1834
Incidence of interval colorectal cancer attributable to an endoscopist in clinical practice 10.1016/j.gie.2018.05.012
Direct-to-consumer telehealth may increase access to care but does not decrease spending 10.1377/hlthaff.2016.1130
Health center implementation of telemedicine for opioid use disorders: A qualitative assessment of adopters and nonadopters 10.1016/j.jsat.2020.108037
Association of characteristics of psychiatrists with use of telemental health visits in the medicare population 10.1001/jamapsychiatry.2019.0052
Variation in pathologist classification of colorectal adenomas and serrated polyps 10.1038/ajg.2017.496
The emergence and promise of telelactation 10.1016/j.ajog.2017.04.043
Impact of race/ethnicity and socioeconomic status on risk-adjusted readmission rates: Implications for the hospital readmissions reduction program 10.1177/0046958016667596
Changes in hospital utilization three years into Maryland's global budget program for rural hospitals 10.1377/hlthaff.2018.0112
Leveraging Telehealth to Bring Volunteer Physicians into Underserved Communities 10.1089/tmj.2016.0174
Evaluation of a center of excellence program for spine surgery 10.1097/MLR.0b013e31829b091d
Associations between physician characteristics and quality of care 10.1001/archinternmed.2010.307
Walk-in clinics versus physician offices and emergency rooms for urgent care and chronic disease management 10.1002/14651858.CD011774
Variation in quality of urgent health care provided during commercial virtual visits 10.1001/jamainternmed.2015.8248
Accountable care organization formation is associated with integrated systems but not high medical spending 10.1377/hlthaff.2013.0372
Retail clinic visits and receipt of primary care 10.1007/s11606-012-2243-x
Cost-sharing obligations, high-deductible health plan growth, and shopping for health care: Enrollees with skin in the game 10.1001/jamainternmed.2015.7554
How is telemedicine being used in opioid and other substance use disorder treatment? 10.1377/hlthaff.2018.05134
Effect of teledermatology on access to dermatology care among medicaid enrollees 10.1001/jamadermatol.2016.0938
Medicare's step back from global payments - Unbundling postoperative care 10.1056/NEJMp1415483
Preventive health examinations and preventive gynecological examinations in the United States 10.1001/archinte.167.17.1876
Antibiotic prescribing for acute respiratory infections in direct-to-consumer telemedicine visits 10.1001/jamainternmed.2015.2024
Use of tele-mental health in conjunction with in-person care: A qualitative exploration of implementation models 10.1176/
Why do patients seek care at retail clinics, and what alternatives did they consider? 10.1177/1062860609353201
Racial and ethnic disparities in pneumonia treatment and mortality 10.1097/MLR.0b013e3181a80fdc
Does Enrollment in High-Deductible Health Plans Encourage Price Shopping? 10.1111/1475-6773.12784
Association between Medicare's Mandatory Joint Replacement Bundled Payment Program and Post-Acute Care Use in Medicare Advantage 10.1001/jamasurg.2019.3957
The Impact of Conversion From an Urgent Care Center to a Freestanding Emergency Department on Patient Population, Conditions Managed, and Reimbursement 10.1016/j.jemermed.2018.12.011
How do pregnant women use quality measures when choosing their obstetric provider? 10.1111/birt.12273
The convenience revolution for treatment of low-acuity conditions 10.1001/jama.2013.6825
Adoption of telemedicine services by substance abuse treatment facilities in the U.S. 10.1016/j.jsat.2020.108060
Sociodemographic characteristics of communities served by retail clinics 10.3122/jabfm.2010.01.090033
Do "Consumer-Directed" health plans bend the cost curve over time? 10.1016/j.jhealeco.2016.01.001
The future ecology of care 10.7326/M15-1978
Treating Patients with Opioid Use Disorder in Their Homes: An Emerging Treatment Model 10.1001/jama.2020.3940
Trends in use of the US medicare annual wellness visit, 2011-2014 10.1001/jama.2017.4342
Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19) 10.1177/1357633X20916567
Direct release of test results to patients increases patient engagement and utilization of care 10.1371/journal.pone.0154743
Do we really need more physicians? Responses to predicted primary care physician shortages 10.1097/MLR.0000000000000046
Prescriptions on Demand: The Growth of Direct-to-Consumer Telemedicine Companies 10.1001/jama.2019.9889
Response: Effectiveness in primary care is paramount, but need not come at the expense of efficiency 10.1097/MLR.0000000000000048
Association Between the Opening of Retail Clinics and Low-Acuity Emergency Department Visits 10.1016/j.annemergmed.2016.08.462
Raising the bar in attribution 10.7326/M17-0655
Changes in hospital bond ratings after the transition to a new electronic health record 10.1093/jamia/ocy007
Challenges in adapting existing clinical natural language processing systems to multiple, diverse health care settings 10.1093/jamia/ocx039
Characteristics of patients who seek care via evisits instead of office visits 10.1089/tmj.2012.0221
Americans support price shopping for health care, but few actually seek out price information 10.1377/hlthaff.2016.1471
Trends among Rural and Urban Medicare Beneficiaries in Care Delivery and Outcomes for Acute Stroke and Transient Ischemic Attacks, 2008-2017 10.1001/jamaneurol.2020.0770
Association between Broadband Internet Availability and Telemedicine Use 10.1001/jamainternmed.2019.2234
Developing a natural language processing application for measuring the quality of colonoscopy procedures 10.1136/amiajnl-2011-000431
Alternative vaccination locations: Who uses them and can they increase flu vaccination rates? 10.1016/j.vaccine.2009.04.055
Who uses a price transparency tool? Implications for increasing consumer engagement 10.1177/0046958017709104
Cost profiles: Should the focus be on individual physicians or physician groups? 10.1377/hlthaff.2009.1091
Offering a price transparency tool did not reduce overall spending among California public employees and retirees 10.1377/hlthaff.2016.1636
Impact of Implementation of Electronically Transmitted Referrals on Pediatric Subspecialty Visit Attendance 10.1016/j.acap.2017.12.008
Changes in health care use associated with the introduction of hospital global budgets in Maryland 10.1001/jamainternmed.2017.7455
Trends in visits to specialist physicians involving nurse practitioners and physician assistants, 2001 to 2013 10.1001/jamainternmed.2017.1630
Use of Adult-Trained Medical Subspecialists by Children Seeking Medical Subspecialty Care 10.1016/j.jpeds.2016.05.073
Quality of care for acute respiratory infections during direct-to-consumer telemedicine visits for adults 10.1377/hlthaff.2018.05091
Association between availability of a price transparency tool and outpatient spending 10.1001/jama.2016.4288
Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures 10.1016/j.gie.2012.01.045
Supply and utilization of pediatric subspecialists in the United States 10.1542/peds.2013-3466
Using clinical vignettes to assess quality of care for acute respiratory infections 10.1177/0046958016636531
Nurse-managed health centers and patient-centered medical homes could mitigate expected primary care physician shortage 10.1377/hlthaff.2013.0596
Disparities in time spent seeking medical care in the United States 10.1001/jamainternmed.2015.4468
Access and quality of care in direct-to-consumer telemedicine 10.1089/tmj.2015.0079
Rapid growth in mental health telemedicine use among rural Medicare beneficiaries, wide variation across states 10.1377/hlthaff.2016.1461
Many emergency department visits could be managed at urgent care centers and retail clinics 10.1377/hlthaff.2009.0748
Use of retail clinics: The authors reply 10.1377/hlthaff.2016.0373
Two-year evaluation of mandatory bundled payments for joint replacement 10.1056/NEJMsa1809010
Home-to-home time — Measuring what matters to patients and payers 10.1056/NEJMp1703423
Variation in dermatologist visits by sociodemographic characteristics 10.1016/j.jaad.2016.10.045
The geographic distribution, ownership, prices, and scope of practice at retail clinics 10.7326/0003-4819-151-5-200909010-00005
Virtual First Responders: the Role of Direct-to-Consumer Telemedicine in Caring for People Impacted by Natural Disasters 10.1007/s11606-018-4440-8
Comparing costs and quality of care at retail clinics with that of other medical settings for 3 common illnesses 10.7326/0003-4819-151-5-200909010-00006
Comparison of physician and computer diagnostic accuracy 10.1001/jamainternmed.2016.6001
Postacute care - The piggy bank for savings in alternative payment models? 10.1056/NEJMp1901896
Care at retail clinics: The author replies 10.1377/hlthaff.2016.0938
Association Between Endoscopist Personality and Rate of Adenoma Detection 10.1016/j.cgh.2018.10.019
The effect of different attribution rules on individual physician cost profiles 10.7326/0003-4819-152-10-201005180-00005
Common Laboratory Results Frequently Misunderstood by a Sample of Mechanical Turk Users 10.1055/s-0039-1679960
Primary care technicians: A solution to the primary care workforce gap 10.1377/hlthaff.2013.0481
Should patients have periodic health examinations? Grand rounds discussion from Beth Israel deaconess medical center 10.7326/M15-2885
A comparison of care at E-visits and physician office visits for sinusitis and urinary tract infection 10.1001/2013.jamainternmed.305
Telemedicine and Outpatient Subspecialty Visits Among Pediatric Medicaid Beneficiaries 10.1016/j.acap.2020.03.014
Use of Commercial Direct-to-Consumer Telemedicine by Children 10.1016/j.acap.2018.11.016
Impact of race/ethnicity and socioeconomic status on risk-adjusted hospital readmission rates following hip and knee arthroplasty 10.2106/JBJS.15.00884
Trends in Visits to Acute Care Venues for Treatment of Low-Acuity Conditions in the United States from 2008 to 2015 10.1001/jamainternmed.2018.3205
Provincial screening rates for chronic diseases of lifestyle, cancers and HIV in a health-insured population 10.7196/SAMJ.6686
Optimizing telehealth strategies for subspecialty care: Recommendations from rural pediatricians 10.1089/tmj.2014.0186
The impact of health plan physician-tiering on access to care 10.1007/s11606-010-1607-3
Evidence and Implications Behind a National Decline in Primary Care Visits 10.1007/s11606-019-05104-5
Family Perspectives on High-Quality Pediatric Subspecialty Referrals 10.1016/j.acap.2016.05.147
Physician cost profiling - Reliability and risk of misclassification 10.1056/NEJMsa0906323
The long term effects of “Consumer-Directed” health plans on preventive care use 10.1016/j.jhealeco.2017.06.008
A health plan's formulary led to reduced use of extended-release opioids but did not lower overall opioid use 10.1377/hlthaff.2018.0391
Primary care practitioners' perceptions of electronic consult systems: A qualitative analysis 10.1001/jamainternmed.2018.0738
Patterns of Postoperative Visits Among Medicare Fee-for-service Beneficiaries 10.1097/SLA.0000000000003168
The effect of telehealth on spending: Thinking through the numbers 10.7326/M17-3070
Post-acute referral patterns for hospitals and implications for bundled payment initiatives 10.1016/j.hjdsi.2014.05.004
Estimating the costs of medicalization 10.1016/j.socscimed.2010.02.019
Response to: "Comment on Patterns of Postoperative Visits among Medicare Fee-for-Service Beneficiaries" 10.1097/SLA.0000000000003565
Primary care practice response to retail clinics 10.1001/virtualmentor.2013.15.11.ecas3-1311
Tipping the balance toward fewer antibiotics 10.1001/jamainternmed.2016.6254
The Impact of Using Mid-level Providers in Face-to-Face Primary Care on Health Care Utilization 10.1097/MLR.0000000000000590
Physician characteristics associated with higher adenoma detection rate 10.1016/j.gie.2017.08.023
Retail clinic visits for low-acuity conditions increase utilization and spending 10.1377/hlthaff.2015.0995
Patients who choose primary care physicians based on low office visit price can realize broader savings 10.1377/hlthaff.2016.0408
Including physicians in bundled hospital care payments: time to revisit an old idea? 10.1001/jama.2015.3359
Reducing unnecessary antibiotics prescribed to children: What next? 10.1542/peds.2013-4016
The authors reply 10.1056/NEJMc1010310
Payment for services rendered - Updating Medicare's valuation of procedures 10.1056/NEJMp1908706
Dropping the baton: Specialty referrals in the United States 10.1111/j.1468-0009.2011.00619.x
Did Hospital Readmissions Fall Because Per Capita Admission Rates Fell? 10.1377/hlthaff.2019.00411
Promise and reality of price transparency 10.1056/NEJMhpr1715229
Episode-based performance measurement and payment: Making it a reality 10.1377/hlthaff.28.5.1406
Los Angeles safety-net program econsult system was rapidly adopted and decreased wait times to see specialists 10.1377/hlthaff.2016.1283
Association of a national insurer's reference-based pricing program and choice of imaging facility, spending, and utilization 10.1111/1475-6773.13279
Adverse inpatient outcomes during the transition to a new electronic health record system: Observational study 10.1136/bmj.i3835
Does price transparency legislation allow the uninsured to shop for care? 10.1007/s11606-009-1176-5
Evaluation of symptom checkers for self diagnosis and triage: Audit study 10.1136/bmj.h3480
The authors reply 10.1056/NEJMc1004716
Endoscopist factors that influence serrated polyp detection: A multicenter study 10.1055/a-0597-1740
Computer-Assisted provision of hormonal contraception in acute care settings 10.1016/j.contraception.2012.07.003
Incorporating statistical uncertainty in the use of physician cost profiles 10.1186/1472-6963-10-57
Impact of socioeconomic adjustment on physicians' relative cost of care 10.1097/MLR.0b013e31828d1251
Family Perspectives on Telemedicine for Pediatric Subspecialty Care 10.1089/tmj.2016.0236
What Drives Variation in Antibiotic Prescribing for Acute Respiratory Infections? 10.1007/s11606-016-3643-0
The association between health care quality and cost a systematic review 10.7326/0003-4819-158-1-201301010-00006
Implementation Science Workshop: Implementation of an Electronic Referral System in a Large Academic Medical Center 10.1007/s11606-015-3516-y
Use patterns of a state health care price transparency web site: What do patients shop for? 10.1177/0046958014561496
National rates of initiation and intensification of antidiabetic therapy among patients with commercial insurance 10.2337/dc17-2585
Reliability of utilization measures for primary care physician profiling 10.1016/j.hjdsi.2013.04.002
Estimating Surgical Procedure Times Using Anesthesia Billing Data and Operating Room Records 10.1111/1475-6773.12474
Geographic variation in receipt of psychotherapy in children receiving attention-deficit/hyperactivity disorder medications 10.1001/jamapediatrics.2014.1647
National trends in primary care visit use and practice capabilities, 2008-2015 10.1370/afm.2474
Comparing costs and quality of care at retail clinics with those of other medical settings [8] 10.7326/0003-4819-152-4-201002160-00022
Assessment of Telestroke Capacity in US Hospitals 10.1001/jamaneurol.2020.1274
Trends in access to primary care for children in the United States, 2002-2013 10.1001/jamapediatrics.2016.0985
Visits to retail clinics grew fourfold from 2007 to 2009, although their share of overall outpatient visits remains low 10.1377/hlthaff.2011.1128
Evaluation of Artificial Intelligence-Based Grading of Diabetic Retinopathy in Primary Care 10.1001/jamanetworkopen.2018.2665
Authors' response 10.1542/peds.2019-1786C
What type of price transparency do we need in health care? 10.7326/M19-0534
The opportunity costs of informal elder-care in the United States: New estimates from the American Time Use Survey 10.1111/1475-6773.12238
Association Of Medicare's Annual Wellness Visit With Cancer Screening, Referrals, Utilization, And Spending 10.1377/hlthaff.2019.00304
Adenoma Detection Rate Falls at the End of the Day in a Large Multi-site Sample 10.1007/s10620-018-4947-1
Hospital and regional variation in medicare payment for inpatient episodes of care 10.1001/jamainternmed.2015.0674
Response to Comment on “Patterns of Postoperative Visits among Medicare Fee-for-service Beneficiaries” 10.1097/SLA.0000000000003346
Practices caring for the underserved are less likely to adopt medicare's annual wellness visit 10.1377/hlthaff.2017.1130
Early marketplace enrollees were older and used more medication than later enrollees; marketplaces pooled risk 10.1377/hlthaff.2015.0016
A study of telecontraception 10.1056/NEJMc1907545
Analysis of teladoc use seems to indicate expanded access to care for patients without prior connection to a provider 10.1377/hlthaff.2013.0989
Pay for performance in the hospital setting: What is the state of the evidence? 10.1177/1062860608326634